Flora Berisha

Bristol Myers Squibb
Princeton, United States

PAPER Vanmechelen E, Vanderstichele H, Davidsson P, Van Kerschaver E, Van Der Perre B, Sjögren M, Andreasen N, Blennow K

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

Neurosci Lett. 2000 May 5;285(1):49-52. PubMed: 10788705

Louise Platts

Cambridge Cognition Ltd
Bottisham

Roy Jones

RICE (The Research Institute for the Care of Older People)
Bath

Tao Wang

Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine
Shanghai, China

Pontus Forsell

Alzecure Foundation
Sweden

Ira Laufer

Rancho MIrage, United States

PAPER Tato RE, Frank A, Hernanz A

Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type.

J Neurol Neurosurg Psychiatry. 1995 Sep;59(3):280-3. PubMed: 7545739

PAPER Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

Mol Chem Neuropathol. 1995 Dec;26(3):231-45. PubMed: 8748926

B Rao

�
United Kingdom

PAPER Boassa D, Berlanga ML, Yang MA, Terada M, Hu J, Bushong EA, Hwang M, Masliah E, George JM, Ellisman MH

Mapping the subcellular distribution of α-synuclein in neurons using genetically encoded probes for correlated light and electron microscopy: implications for Parkinson's disease pathogenesis.

J Neurosci. 2013 Feb 6;33(6):2605-15. PubMed: 23392688

PAPER Liddell JR, Obando D, Liu J, Ganio G, Volitakis I, Mok SS, Crouch PJ, White AR, Codd R

Lipophilic adamantyl- or deferasirox-based conjugates of desferrioxamine B have enhanced neuroprotective capacity: implications for Parkinson disease.

Free Radic Biol Med. 2013 Feb 4;60C:147-156. PubMed: 23391576

PAPER Jetha NN, Semenchenko V, Wishart DS, Cashman NR, Marziali A

Nanopore analysis of wild-type and mutant prion protein (PrP(C)): single molecule discrimination and PrP(C) kinetics.

PLoS One. 2013;8(2):e54982. PubMed: 23393562

PAPER Taylor DM, Moser R, Régulier E, Breuillaud L, Dixon M, Beesen AA, Elliston L, Silva Santos Md, Kim J, Jones L, Goldstein DR, Ferrante RJ, Luthi-Carter R

MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition.

J Neurosci. 2013 Feb 6;33(6):2313-25. PubMed: 23392662

PAPER Khan MM, Kempuraj D, Thangavel R, Zaheer A

Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol.

Neurochem Int. 2013 Mar;62(4):379-88. PubMed: 23391521